Skip to contentClarengateINTELLIGENCE
Companies/11660861

Pencil Biosciences Limited

Research and experimental development on biotechnology · Macclesfield

ActiveUnited KingdomIncorporated 2018Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2026-08-31

IXBRL · 78 source facts · 19 selected values

Validation findings
XBRL valid
Reporting period
2025-09-01 to 2026-08-31
Extraction status
complete
Numeric facts
35
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod223_4305_11660861_20260831
Source archive
Accounts_Bulk_Data-2026-09-11.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2023-08-31

IXBRL · 139 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2022-09-01 to 2023-08-31
Extraction status
Legacy / not assessed
Numeric facts
82
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_0032_11660861_20230831
Source archive
Accounts_Monthly_Data-November2023.zip

Accounts to 2022-08-31

IXBRL · 150 source facts · 24 selected values

Not assessed
legacy record
Reporting period
2021-10-01 to 2022-08-31
Extraction status
Legacy / not assessed
Numeric facts
89
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0110_11660861_20220831
Source archive
Accounts_Monthly_Data-September2022.zip

Accounts to 2021-09-30

IXBRL · 144 source facts · 24 selected values

Not assessed
legacy record
Reporting period
2020-10-01 to 2021-09-30
Extraction status
Legacy / not assessed
Numeric facts
89
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0100_11660861_20210930
Source archive
Accounts_Monthly_Data-January2022.zip

Accounts to 2020-09-30

IXBRL · 132 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2019-10-01 to 2020-09-30
Extraction status
Legacy / not assessed
Numeric facts
82
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0083_11660861_20200930
Source archive
Accounts_Monthly_Data-October2020.zip

Accounts to 2019-09-30

IXBRL · 55 source facts · 6 selected values

Not assessed
legacy record
Reporting period
2018-11-05 to 2019-09-30
Extraction status
Legacy / not assessed
Numeric facts
16
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0075_11660861_20190930
Source archive
Accounts_Monthly_Data-February2020.zip

Registered details

11660861
Status
Active
Type
Private Limited Company
Incorporated
2018-11-05
Jurisdiction
—
Registered office
21G1 MERESIDE, ALDERLEY PARK, MACCLESFIELD, CHESHIRE, SK10 4TG, UNITED KINGDOM

Classification

1 SIC codes
72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

1 SH01-derived rounds
2023-08-16
£5,730,867 raised
£6,905,539 estimated post-money
Venture

Research and innovation

3 matched grants
Novel, synthetic gene editing technology for gene knock-ins without DNA cleavageLead
Innovate UK · Investment Accelerator · 2023-05-01 – 2025-04-30
£685,193
awarded
Development and characterisation of a novel artificial genome editing toolLead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£72,570
awarded
Developing a Novel, Precise and Programmable Genome Editing TechnologyLead
Innovate UK · Collaborative R&D · 2019-11-01 – 2021-05-31
£197,085
awarded